Evidence map›Paper›PMID 38497259›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2024

When the microbiome shapes the host: immune evolution implications for infectious disease.

Mark A Hanson

Open access · hybridAbstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
17.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 32 citations in OpenAlex.

  1. Molecular evolution of animal aging.The EMBO journal · 2026
    Review
  2. Article
  3. Article
  4. Frontiers in cellular and infection microbiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Infection and immunity · 2025
    Review
  10. Article
  11. Sculpting the microbiome.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  12. Evolutionary immunology to explore original antiviral strategies.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  13. A new lexicon in the age of microbiome research.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  14. Cereal weevils' antimicrobial peptides: at the crosstalk between development, endosymbiosis and immune response.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Mark A HansonCentre for Ecology and Conservation, University of Exeter, Cornwall, TR10 9FE, UK.ORCID 0000-0002-6125-3672
University of Exeter · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The microbiome includes both 'mutualist' and 'pathogen' microbes, regulated by the same innate immune architecture. A major question has therefore been: how do hosts prevent pathogenic infections while maintaining beneficial microbes? One idea suggests hosts can selectively activate innate immunity upon pathogenic infection, but not mutualist colonization. Another idea posits that hosts can selectively attack pathogens, but not mutualists. Here I review evolutionary principles of microbe recognition and immune activation, and reflect on newly observed immune effector-microbe specificity perhaps supporting the latter idea. Recent work in

Indexed as

Communicable DiseasesMicrobiotaAnimalsDrosophilaHost-Pathogen InteractionsImmunity, InnateMammalsSymbiosisantimicrobial peptidehost defence peptidehost–microbe interactionshost–pathogenmicrobiotareactive oxygen species

Identifiers

PMID38497259
PMCPMC10945400
OpenAlexW4392916219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.